# Experimental Vaccine Extends Life in Severe Leukemia Cases

> Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients.
- Title: Experimental Vaccine Extends Life in Severe Leukemia Cases
- Summary: Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients.
- Keywords: leukemia, acute myeloid leukemia, experimental vaccine, survival rate, sellas life sciences, fda approval, CNN Brasil
- URL: https://shortify.news/CNN_Brasil/experimental-vaccine-extends-life-in-severe-leukemia-cases
- Source: CNN Brasil — https://cnnbrasil.com.br/saude/vacina-experimental-aumenta-sobrevida-em-casos-de-leucemia-grave
- Author: Helena Barra
- Published: 2026-11-20T20:29:06+00:00
- Read time: 1 min
- Topics: leukemia, acute myeloid leukemia, experimental vaccine, survival rate, sellas life sciences, fda approval, news
## Experimental Vaccine Boosts Survival
A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy.
## How the Vaccine Works
The vaccine trains the patient's immune system to recognize and destroy residual cancer cells after chemotherapy.
## Key Results of Study
The study showed a 41% reduction in mortality risk and a median survival of 24 months for patients receiving the vaccine.
## Next Steps for Approval
SELLAS Life Sciences plans to discuss FDA approval pathways with the U.S. agency by early 2027.
## Key takeaway

A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy.

---

Summary: Shortify — https://shortify.news/CNN_Brasil/experimental-vaccine-extends-life-in-severe-leukemia-cases
Reporting: CNN Brasil — https://cnnbrasil.com.br/saude/vacina-experimental-aumenta-sobrevida-em-casos-de-leucemia-grave

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.